CountryOfPapers CountryOfPapers
Journal list Promote Sponsor
verified SJR 0,131 · Q4 • database DOAJ indexed
Multiple Sclerosis and Demyelinating Disorders
United Kingdom · BioMed Central Ltd.
workspace_premium Q4 — Immunology verified Plan S Compliant visibility_off Single blind Peer Review lock_open Open Access · DOAJ

Multiple Sclerosis and Demyelinating Disorders

Multiple Sclerosis and Demyelinating Disorders is a journal indexed in SJR in Immunology and Immunology and Allergy with an H index of 2. It is an CC BY Journal with a Single blind Peer Review review system, and It has a price of 1507 €. The scope of the journal is focused on multiple sclerosis, neuromyelitis optica, demyelinating diseases, diseases of the central nervous system, clinical care. It has an SJR impact factor of 0,131 and it has a best quartile of Q4. It is published in English. It has an SJR impact factor of 0,131.

Publisher: BioMed Central Ltd.
Category: Immunology
Indexation: verifiedDOAJ
open_in_new Portal NPD menu_book Author guidelines
schedule CountryOfPapers database fields
SJR Impact Factor trending_up
0,131 Q4
H-index 2
Acceptance rate pie_chart
84%
Source Acceptance_Rate
Time to publication hourglass_top
29 weeks
Field Average_time_publication_weeks
Publication cost (APC) payments
1.507 € Open Access
Non-OA path NPD

Metrics

Scimago and CountryOfPapers database fields

DOAJ

SJR Impact

0,131

H-index

2

Docs (year)

0

Docs 3y

1

Total refs

0

Cites 3y

0

Citable 3y

1

Cites/Doc 2y

0

Ref/Doc

0.0

Immediate OA

1507 €

Embargoed OA

NPD

Non OA / Submission

- €

shield Researcher voice

Name good journals. Call out predatory ones.

Share what peer review, fees, and timelines were really like. Praise fair editors. Flag APC traps, fake metrics, or spam solicitations — with facts from your submission.

Fair & fast peer review Clear APC / no surprise fees Suspected predatory Fake impact claims
rate_review Write an honest review

Researcher reviews

sentiment_dissatisfied No reviews yet — be the first to share an honest experience.
User
* Only to validate authenticity — identity is not shown publicly.

FAQs

What is the SJR of Multiple Sclerosis and Demyelinating Disorders?

Multiple Sclerosis and Demyelinating Disorders has an SJR of 0,131 (best quartile Q4) in the CountryOfPapers database.

What is the APC / publication cost?

Immediate OA APC is 1507 EUR.

What is the acceptance rate?

The acceptance rate recorded for Multiple Sclerosis and Demyelinating Disorders is 84%.